- Home
- PCRX vs YALA Comparison
PCRX vs YALA Comparison
Compare PCRX & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- YALA
- Stock Information
- Founded
- PCRX 2006
- YALA 2016
- Country
- PCRX United States
- YALA United Arab Emirates
- Employees
- PCRX N/A
- YALA N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- YALA Computer Software: Programming Data Processing
- Sector
- PCRX Health Care
- YALA Technology
- Exchange
- PCRX Nasdaq
- YALA Nasdaq
- Market Cap
- PCRX 1.2B
- YALA 1.1B
- IPO Year
- PCRX 2011
- YALA 2020
- Fundamental
- Price
- PCRX $26.25
- YALA $6.67
- Analyst Decision
- PCRX Buy
- YALA
- Analyst Count
- PCRX 9
- YALA 0
- Target Price
- PCRX $29.89
- YALA N/A
- AVG Volume (30 Days)
- PCRX 891.6K
- YALA 1.4M
- Earning Date
- PCRX 05-08-2025
- YALA 05-19-2025
- Dividend Yield
- PCRX N/A
- YALA N/A
- EPS Growth
- PCRX N/A
- YALA 8.53
- EPS
- PCRX N/A
- YALA 0.77
- Revenue
- PCRX $702,772,000.00
- YALA $344,824,034.00
- Revenue This Year
- PCRX $8.63
- YALA $9.21
- Revenue Next Year
- PCRX $11.66
- YALA $5.98
- P/E Ratio
- PCRX N/A
- YALA $8.96
- Revenue Growth
- PCRX 3.08
- YALA 6.40
- 52 Week Low
- PCRX $11.16
- YALA $3.71
- 52 Week High
- PCRX $31.64
- YALA $8.29
- Technical
- Relative Strength Index (RSI)
- PCRX 49.37
- YALA 41.35
- Support Level
- PCRX $25.33
- YALA $6.91
- Resistance Level
- PCRX $26.44
- YALA $8.15
- Average True Range (ATR)
- PCRX 0.91
- YALA 0.44
- MACD
- PCRX -0.03
- YALA -0.17
- Stochastic Oscillator
- PCRX 61.96
- YALA 35.68
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.